Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Acridine, 9-(p-dimethylaminoanilino)-
RN: 13365-38-3
InChIKey: WBERNRVMJQYKKR-UHFFFAOYSA-N

Classification Codes

  • Drug / Therapeutic Agent
  • Mutation Data

Molecular Formula

  • C21-H19-N3

Molecular Weight

  • 313.402
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Synonyms

  • 9-((p-(Dimethylamino)phenyl)amino)acridine
  • 9-(p-Dimethylaminoanilino)acridine
  • Acridine, 9-((p-(dimethylamino)phenyl)amino)-
  • Acridine, 9-(p-dimethylaminoanilino)-
  • BRN 0487364
  • N'-9-Acridinyl-N,N-dimethyl-1,4-benzenediamine
  • NSC 13002
  • WIN 1701

Systematic Names

  • 1,4-Benzenediamine, N'-9-acridinyl-N,N-dimethyl- (9CI)
  • Acridine, 9-((p-(dimethylamino)phenyl)amino)- (8CI)
  • Acridine, 9-(p-dimethylaminoanilino)-

Registry Numbers

CAS Registry Number

  • 13365-38-3

System Generated Number

  • 0013365383

Structure Descriptors

InChI

1S/C21H19N3/c1-24(2)16-13-11-15(12-14-16)22-21-17-7-3-5-9-19(17)23-20-10-6-4-8-18(20)21/h3-14H,1-2H3,(H,22,23)

InChIKey

WBERNRVMJQYKKR-UHFFFAOYSA-N

Smiles

c1(c2c(nc3c1cccc3)cccc2)Nc1ccc(N(C)C)cc1

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous 5mg/kg (5mg/kg) BEHAVIORAL: ATAXIA

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. Vol. -, Pg. 326, 1967.
monkey LDLo intravenous 5mg/kg (5mg/kg) CARDIAC: PULSE RATE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. Vol. -, Pg. 326, 1967.
mouse LD50 intraperitoneal 80970ug/kg (80.97mg/kg)   National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
rat LD50 intravenous 15mg/kg (15mg/kg)   Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. Vol. -, Pg. 326, 1967.